Abstract
Changes in brain function during the initial weeks of abstinence from chronic methamphetamine abuse may substantially affect clinical outcome, but are not well understood. We used positron emission tomography with [F-18]fluorodeoxyglucose (FDG) to quantify regional cerebral glucose metabolism, an index of brain function, during performance of a vigilance task. A total of 10 methamphetamine-dependent subjects were tested after 5–9 days of abstinence, and after 4 additional weeks of supervised abstinence. A total of 12 healthy control subjects were tested at corresponding times. Global glucose metabolism increased between tests (P=0.01), more in methamphetamine-dependent (10.9%, P=0.02) than control subjects (1.9%, NS). Glucose metabolism did not change in subcortical regions of methamphetamine-dependent subjects, but increased in neocortex, with maximal increase (>20%) in parietal regions. Changes in reaction time and self-reports of negative affect varied more in methamphetamine-dependent than in control subjects, and correlated both with the increase in parietal glucose metabolism, and decrease in relative activity (after scaling to the global mean) in some regions. A robust relationship between change in self-reports of depressive symptoms and relative activity in the ventral striatum may have great relevance to treatment success because of the role of this region in drug abuse-related behaviors. Shifts in cortical–subcortical metabolic balance either reflect new processes that occur during early abstinence, or the unmasking of effects of chronic methamphetamine abuse that are obscured by suppression of cortical glucose metabolism that continues for at least 5–9 days after cessation of methamphetamine self-administration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 2004; 61: 73–84.
Paulus MP, Hozack N, Frank L, Brown GG, Schuckit MA . Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry 2003; 53: 65–74.
Monterosso JR, Aron AR, Cordova X, Xu J, London ED . Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 2005; 79: 273–277.
Kalechstein AD, Newton TF, Green M . Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Neurophysiol Clin 2003; 15: 215–220.
Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP et al. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res 2002; 111: 65–74.
London E, Berman S, Voytek B, Simon S, Monterosso J, Geaga J et al. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry 2005; 58: 770–778.
Hwang J, Lyoo IK, Kim SJ, Sung YH, Bae S, Cho SN et al. Decreased cerebral blood flow of the right anterior cingulate cortex in long-term and short-term abstinent methamphetamine users. Drug Alcohol Depend 2006; 82: 177–181.
Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler MT et al. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry 2001; 158: 383–389.
Wang G-J, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R et al. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 2004; 161: 242–248.
Brecht ML, von Mayrhauser C, Anglin MD . Predictors of relapse after treatment for methamphetamine use. J Psychoactive Drugs 2000; 32: 211–220.
Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE . Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371–388.
Beck AT, Steer RA . Manual for the Revised Beck Depression Inventory. Psychological Corporation: San Antonio, TX, 1987.
Denckla MB . Revised neurological examination for subtle signs (1985). Psychopharmacol Bull 1985; 21: 773–800.
First MB, Spitzer RL, Gibbon M, Williams J . Structured Clinical Interview for DSM-IV Axis I Disorders—Patient Edition (SCID-IP, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute: New York, NY, 1996.
Huang S-C, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE . Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980; 238: E69–E82.
McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM . The nature, time course and severity of methamphetamine withdrawal. Addiction 2005; 100: 1320–1329.
Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W . Methamphetamine abstinence syndrome: Preliminary findings. Am J Addict 2002; 13: 248–255.
Koob GF . Neural mechanisms of drug reinforcement. Ann N Y Acad Sci 1992; 654: 171–191.
Hammer Jr RP, Pires WS, Markou A, Koob GF . Withdrawal following cocaine self-administration decreases regional cerebral metabolic rate in critical brain reward regions. Synapse 1993; 14: 73–80.
Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP et al. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci 2001; 937: 1–26.
Pennypacker KR, Kassed CA, Eidizadeh S, O'Callaghan JP . Brain injury: prolonged induction of transcription factors. Acta Neurobiol Exp (Wars) 2000; 60: 515–530.
McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA . Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 1998; 18: 8417–8422.
Volkow ND, Chang L, Wang G-J, Fowler JS, Franceschi D, Sedler M et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001; 21: 9414–9418.
LaVoie MJ, Card JP, Hastings TG . Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp Neurol 2004; 187: 47–57.
Roh JK, Nam H, Lee MC . A case of central pontine and extrapontine myelinolysis with early hypermetabolism on 18FDG-PET scan. J Korean Med Sci 1998; 13: 99–102.
Bowyer JF, Clausing P, Gough B, Slikker Jr W, Holson RR . Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res 1995; 699: 62–70.
Ernst T, Chang L, Leonido-Yee M, Speck O . Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology 2000; 54: 1344–1349.
Nordahl TE, Salo R, Possin K, Gibson DR, Flynn N, Leamon M et al. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res 2002; 116: 43–52.
Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 2001; 158: 1206–1214.
Smith LM, Chang L, Yonekura ML, Grob C, Osborn D, Ernst T . Brain proton magnetic resonance spectroscopy and imaging in children exposed to methamphetamine in utero. Neurology 2001; 57: 255–260.
Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD et al. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2005; 62: 444–452.
O'Neill JO, Monterosso J, Walker MK, London ED . 1H MRSI brain findings in chronic methamphetamine abuse. Program 392.9 2006 Neuroscience Meeting Planner. Soc Neurosci 2006 online.
Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M et al. Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. Neuropsychopharmacology 1999; 20: 565–581.
London ED, Grant SJ, Morgan MJ, Zukin SR . Neurobiology of drug abuse. In: Fogel BS, Schiffer RB, Rao SM (eds). Neuropsychiatry. William & Wilkins: Baltimore 1996 pp 635–678.
London ED, Broussolle EP, Links JM, Wong DF, Cascella NG, Dannals RF et al. Morphine-induced metabolic changes in human brain. Studies with positron emission tomography and [fluorine 18]fluorodeoxyglucose. Arch Gen Psychiatry 1990; 47: 73–81.
Theodore WH, DiChiro G, Margolin R, Fishbein D, Porter RJ, Brooks RA . Barbiturates reduce human cerebral glucose metabolism. Neurology 1986; 36: 60–64.
Foster NL, VanDerSpek AFL, Aldrich MS, Berent S, Hichwa RH, Sackellares JC et al. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography. J Cereb Blood Flow Metab 1987; 7: 415–420.
London ED, Cascella NG, Wong DF, Phillips RL, Dannals RF, Links JM et al. Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch Gen Psychiatry 1990; 47: 567–574.
Wolkin A, Angrist B, Wolf A, Brodie J, Wolkin B, Jaeger J et al. Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacology (Berl) 1987; 92: 241–246.
Cannon WB . The James–Lange theory of emotions: a critical examination and an alternative theory. Am J Psychol 1927; 39: 106–124.
Huang MX, Lee RR, Miller GA, Thoma RJ, Hanlon FM, Paulson KM et al. A parietal-frontal network studied by somatosensory oddball MEG responses, and its cross-modal consistency. Neuroimage 2005; 28: 99–114.
Nieuwenhuis S, Aston-Jones G, Cohen JD . Decision making, the P3, and the locus coeruleus-norepinephrine system. Psychol Bull 2005; 131: 510–532.
Polich J, Criado JR . Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol 2006; 60: 172–185.
Takeuchi S, Jodo E, Suzuki Y, Matsuki T, Niwa S, Kayama Y . Effects of repeated administration of methamphetamine on P3-like potentials in rats. Int J Psychophysiol 1999; 32: 183–192.
Iwanami A, Suga I, Kaneko T, Sugiyama A, Nakatani Y . P300 component of event-related potentials in methamphetamine psychosis and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 465–475.
Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD et al. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2005; 62: 444–452.
Thompson PM, Hayashi K, Simon SL, Geaga JA, Hong MS, Sui Y et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24: 6028–6036.
Oh JS, Lyoo IK, Sung YH, Hwang J, Kim J, Chung A et al. Shape changes of the corpus callosum in abstinent methamphetamine users. Neurosci Lett 2005; 384: 76–81.
Jernigan TL, Gamst AC, Archibald SL, Fennema-Notestine C, Mindt MR, Marcotte TD et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 2005; 162: 1461–1472.
Draganski B, Gaser C, Busch V, Schuierer G, Bogdahn U, May A . Neuroplasticity: changes in grey matter induced by training. Nature 2004; 427: 311–312.
Acknowledgements
We gratefully acknowledge the following support from the National Institute of Health: Grants 5RO1 DA 15179 and 5RO1 DA 020726 (to EDL), MOI RR 00865 and contract 1 Y01 DA 50038 (to EDL, WL). Preliminary reports have been presented in abstracts at the following annual meetings: American College of Neuropsychopharmacology, Waikoloa, HI, 8 December 2001; American Psychiatric Association, Philadelphia, PA, 18 May 2002; Cognitive Neuroscience Society, San Francisco, CA, 14 April 2002; XXIII CINP Congress, Montreal, Canada, 23 June 2002; Society for Neuroscience, Atlanta, GA, 14 October 2006.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berman, S., Voytek, B., Mandelkern, M. et al. Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Mol Psychiatry 13, 897–908 (2008). https://doi.org/10.1038/sj.mp.4002107
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4002107
Keywords
This article is cited by
-
Acute and protracted abstinence from methamphetamine bidirectionally changes intrinsic excitability of indirect pathway spiny projection neurons in the dorsomedial striatum
Scientific Reports (2022)
-
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
European Journal of Nuclear Medicine and Molecular Imaging (2022)
-
A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells
Nature Biotechnology (2018)
-
Exercise during early, but not late abstinence, attenuates subsequent relapse vulnerability in a rat model
Translational Psychiatry (2016)
-
Persistent Microstructural Deficits of Internal Capsule in One-Year Abstinent Male Methamphetamine Users: a Longitudinal Diffusion Tensor Imaging Study
Journal of Neuroimmune Pharmacology (2016)